U.D. Drugs Company Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.11 M
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 65.80%
- Ebitda 65.80%
- Net Worth -4.87%
- Total Assets -4.67%
About U.D. Drugs Company
U.D. Drugs Company Private Limited (UDCPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 October 2013 and has a history of 11 years and three months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Newatia and Asha Newatia serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900WB2013PTC198074
-
Company No.
198074
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Oct 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at U.D. Drugs Company?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Newatia
|
Director | 24-Oct-2013 | Current |
|
Asha Newatia
|
Additional Director | 13-Aug-2022 | Current |
Financial Performance of U.D. Drugs Company.
U.D. Drugs Company Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 65.8% increase in profit. The company's net worth dipped by a decrease of 4.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of U.D. Drugs Company?
Unlock access to U.D. Drugs Company's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
R P Developers Private LimitedRajendra Newatia is a mutual person
-
Ritesh Commercial Holdings LtdRajendra Newatia is a mutual person
-
Rupali Trade & Holdings (India) Pvt Ltd
Rajendra Newatia is a mutual person
-
Swarnapushpa Vanijya Private Limited
Rajendra Newatia is a mutual person
-
Charisma Combines Pvt Ltd
Rajendra Newatia is a mutual person
-
Shree Balaji Mercantiles Pvt Ltd
Rajendra Newatia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at U.D. Drugs Company?
Unlock and access historical data on people associated with U.D. Drugs Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of U.D. Drugs Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped U.D. Drugs Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
